What PE-22-28 is
Experimental spadin-derived peptide investigated for TREK-1 potassium-channel modulation and antidepressant/neuroplasticity biology. It is also referred to as Spadin analog.
How it works
Designed to inhibit TREK-1 potassium-channel signaling.
What the evidence shows
Evidence is predominantly preclinical.
Evidence level: E — Experimental.
Routes studied: Experimental.
Doses studied: No established human therapeutic dose.
What this page does not claim
PE-22-28 is not an antidepressant treatment.
Safety considerations
Human safety is not established.
- Possible interactions: CNS-active medicines.
Sport and anti-doping
Unknown.
Availability at True Heal Wellness
True Heal Wellness does not offer, sell or administer PE-22-28. This page exists as an educational reference only.